Roll-up of 3 projects. Projects are the summable leaves — the PE total is their sum, never added to it.
For fiscal year 2027, the U.S. Army is requesting $149.2M for Medical Technology under RDT&E program element 0602787A, down 20% from FY2026. In the FY2027 defense authorization, House moved to cut it to $142.2M.
Funding profile, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 64.7 |
| FY2026 | Enacted | 186.8 |
| FY2027 | Request | 149.2 |
| FY2028 | Outyear | 155.3 |
| FY2029 | Outyear | 156.0 |
| FY2030 | Outyear | 158.2 |
| FY2031 | Outyear | 156.7 |
Acquisition lifecycle
This program is funded in RDT&E Budget Activity 2 — Applied Research.
3 projects roll up into PE 0602787A
Projects are the summable leaves — the PE total is their sum, never added to it. Program elements and projects carry the full five-year plan; activities stop at the budget year. This PE moves -20% overall, which can hide much larger swings below.
Cbt Casualty Care Applied Rsch Technology
Medical Technology (CA)
The request is contested
Committee marks on the FY2027 request. Adds and cuts are reconciled in conference before they become law.
Mission & acquisition strategy
This PE supports application of knowledge gained through basic research to optimize drugs, medical devices, medical practices/procedures, and other preventive measures to include injury predictive strategies and tools essential to the protection and sustainment of Warfighter health and performance. Projects are coordinated with the Defense Health Agency. The cited research is consistent with the Under Secretary of War for Research and Engineering science and technology focus areas and the Army Modernization Strategy. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations.
Ask this program element
Answers are generated from the figures on this page — the FY2027 justification exhibits and the marks tracked above — and nothing else is consulted. Confirm any figure against the cited exhibit before you use it externally.
This page carries the budget justification and the NDAA marks — nothing else. For what a contractor has actually been obligated, the ledger is at hitchintel.com/vendors; for live solicitations, hitchintel.com/opportunities. Both are member surfaces.
Cite this page
/programs/0602787A.md · MCP mcp.hitchintel.com → budget_get_program_element, budget_get_cong_marksWarfigher Health Applied Rsch Technology — one RDT&E project inside PE 0602787A. Congressional marks are recorded on the program element, not on a project.
Project MK4 — Warfigher Health Applied Rsch Technology — requests $147.5M in FY2027, 99% of the $149.2M requested for program element 0602787A. Year over year it grows 4.0% against FY2026.
Project MK4 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 63.6 |
| FY2026 | Enacted | 141.8 |
| FY2027 | Request | 147.5 |
| FY2028 | Outyear | 153.1 |
| FY2029 | Outyear | 153.7 |
| FY2030 | Outyear | 156.3 |
| FY2031 | Outyear | 154.7 |
10 accomplishments / planned programs
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them. Opening lines only here — the full year-by-year narrative is on the project page.
Determine the influences of long-acting reversible contraceptives on physiological responses to extreme environments in women. Provide knowledge to optimize Soldier performance in Arctic Environments. Determine the influence of race and dietary supplementation on skin perfusion in the cold.
Determine physiological and biochemical markers of exertional heat stroke (EHS) and non -EHS responses to high-risk events. Identify genomic and transcriptomic signature for predicting exertional heat stroke/illness. Determine sex differences in the physiological and metabolic response to strenuous military training in the cold. Develop…
Enhance and optimize methodology for head injury risk assessment.
Investigate biomechanical differences during the ACFT deadlift; continue to determine risk factors for re-injury following a musculoskeletal injury to provide recommendations for preventing subsequent injuries.
Quantify the role of physiological factors, such as fiber type and metabolic elements, contributing to the development of muscle fatigue and decreased performance and risk and mitigation interventions; continue to determine the extent to which sleep extension reduces musculoskeletal injury; continue to identify non-physical factors…
Initiate investigation of machine learning and artificial intelligence analysis to predict individual Soldier and echelon-based medical readiness and impact on physical and mental performance.
Inform the development of targeted nutritional countermeasures for mitigating MSKI-mediated atrophy and accelerate recovery.
Will conduct extensive data analysis and documentation of energy field bioeffects modeling, simulation, laboratory and data collection results across biologically relevant scales.
Read the FY2027 plan →Continued evaluation of translational countermeasures resulting in a go/no go decision supporting advance research to mitigate medical risk and augment performance for Soldier operations in extreme environments. Identify and assess novel interventions to optimize hydration in extreme heat and increase blood oxygen levels at extreme…
Read the FY2027 plan →Develop an initial framework for capturing acute, subacute, and long-term effects of BOP exposure using wearable physiological health and fitness devices to inform injury prevention and recovery strategies. Conduct comparative analysis of PPE effectiveness in mitigating blast effects.
What project MK4 buys
This project conducts research to develop and evaluate solutions to enhance Warfighter health and readiness by preventing non-battle injuries stemming from environmental (heat, cold, altitude, etc.) exposures, informing optimized logistics for nutrition to ensure sustained lethality, and developing comprehensive countermeasures and blast mitigation strategies to enhance Solider performance. This research will directly inform improved training procedures, medical standards, and injury prevention protocols, ultimately reducing injury rates, accelerating recovery, and minimizing long term health consequences and the associated medical costs. Research in this Project is coordinated and is complementary to work done in PE 0602143A (Soldier Lethality Technology) and PE 0603118A (Soldier Lethality Advanced Technology). Work is performed at U.S. Army Research Institute of Environmental Medicine (USARIEM) and the U.S. Army Aeromedical Research Laboratory (USAARL) and Army Research Laboratory (ARL).
Cbt Casualty Care Applied Rsch Technology — one RDT&E project inside PE 0602787A. Congressional marks are recorded on the program element, not on a project.
Project MM4 — Cbt Casualty Care Applied Rsch Technology — requests $1.7M in FY2027, 1.2% of the $149.2M requested for program element 0602787A. Year over year it grows 13% against FY2026.
Project MM4 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 1.1 |
| FY2026 | Enacted | 1.5 |
| FY2027 | Request | 1.7 |
| FY2028 | Outyear | 2.2 |
| FY2029 | Outyear | 2.3 |
| FY2030 | Outyear | 1.9 |
| FY2031 | Outyear | 1.9 |
1 accomplishment / planned program
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them.
FY2027 planned work Complete assessment of the effects of sleep restriction and pharmacological countermeasures on medical provider performance in the en route care environment. Complete preliminary assessment of novel exoskeleton solutions to assist litter carriage in future conflicts. Develop injury criteria for assessing retention of litters and casualties during helicopter crashes. Continue development and integration of device alarms into flight medic helmets with salient cues reducing workload regarding device alarms.
FY2026 to FY2027 change Funding increase reflects planned continuation of this effort.
FY2026 plans — current year Continue to evaluate efficacy of new exoskeleton technologies to reduce rate of injury experienced by litter bearers and dramatically improve the speed and distance of extended litter transport. Continue study of patient-specific in-helmet medical device alarms to determine reaction time and patient outcome during multi-patient medical evacuation scenarios. Continue studying the benefit on patient outcome of providing tier 2 responder training to nonmedical MEDEVAC crewmembers. Evaluate the effect of sleep deprivation on medical provider performance in the prolonged care environment; evaluate efficacy of pharmaceutical performance sustainment methods, previously approved for aircrew (e.g…
FY2025 accomplishments Evaluate new exoskeleton technologies designed to reduce the rate of acute or chronic injury experienced by litter bearers and dramatically improve the speed and distance of extended litter transport. Assess the benefit on patient outcome of providing tier 2 responder training to nonmedical MEDEVAC crewmembers. Continue evaluation of patient-specific medical device alarms used during multi-patient helicopter medical evacuation scenarios. Completion of a final technical report detailing positive findings from operational effectiveness, performance, and biomechanics comparisons of unassisted and assistive devices utilized during several dismounted field transport scenarios.
What project MM4 buys
This project refines and assesses concepts, techniques, and materiel that improve survivability and treatment outcomes for Warfighters wounded during combat operations and treated under austere field conditions, including prolonged field care, and during medical evacuation, and maintains laboratory capability to perform these functions. Combat casualty care research addresses control of severe bleeding; resuscitation and stabilization; advanced automated life support systems suitable for use in forward areas, treatment of severe orthopedic injuries, treatment of severe burns, and combat-related brain injury. Promising efforts identified in this Project are further matured under Program Element (PE) 0603002A (Medical Advanced Technology). Research in this project is performed by the United States Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD.
Medical Technology (CA) — one RDT&E project inside PE 0602787A. Congressional marks are recorded on the program element, not on a project.
Project BS7 — Medical Technology (CA) — requests — in FY2027, 0.0% of the $149.2M requested for program element 0602787A. Year over year it falls 100% against FY2026.
Project BS7 funding, FY2026–FY2026
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2026 | Enacted | 43.5 |
What project BS7 buys
Congressional Interest Item funding provided for Medical Technology.